Literature DB >> 8760306

Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas.

D R de Bruijn1, E Baats, U Zechner, B de Leeuw, M Balemans, D Olde Weghuis, U Hirning-Folz, A G Geurts van Kessel.   

Abstract

In a previous study we reported the isolation of the human synovial sarcoma-associated t(X;18) breakpoint. As a result of this translocation, the SYT gene on chromosome 18 fuses to either the SSX1 or the SSX2 gene on the X chromosome, depending on the exact location of the breakpoint within band Xp11.2. As yet, little is known about the modes of action of the SYT and SSX genes and their respective (fusion) products. Here we report the isolation of the mouse homolog of SYT, its full length cDNA sequence, its chromosomal localization, and its spatio-temporal expression patterns in adult and embryonic tissues. The SYT gene was found to be well conserved during evolution and is part of a region of synteny between the human and mouse chromosomes 18. In early embryogenesis, Syt is ubiquitously expressed. In later stages, the expression becomes confined to cartilage tissues, specific neuronal cells and some epithelial derived tissues. In mature testis, expression was specifically observed in primary spermatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760306

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.

Authors:  Emily E Carmody Soni; Silke Schlottman; Hayriye V Erkizan; Aykut Uren; Jeffrey A Toretsky
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

2.  The proto-oncoprotein SYT (SS18) controls ATP release and regulates cyst formation by polarized MDCK cells.

Authors:  Manesh Chittezhath; Andrea L Frump; Jerome Jourquin; Nichole Lobdell; Josiane E Eid
Journal:  Exp Cell Res       Date:  2008-09-20       Impact factor: 3.905

Review 3.  Novel pathways and molecular targets for the treatment of sarcoma.

Authors:  Ashley E Frith; Angela C Hirbe; Brian A Van Tine
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

4.  Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.

Authors:  Christina B Garcia; Christian M Shaffer; Josiane E Eid
Journal:  BMC Genomics       Date:  2012-05-17       Impact factor: 3.969

5.  Molecular alterations in pediatric sarcomas: potential targets for immunotherapy.

Authors:  T J Goletz; C L Mackall; J A Berzofsky; L J Helman
Journal:  Sarcoma       Date:  1998

6.  Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma.

Authors:  E Tamborini; V Agus; A Mezzelani; C Riva; G Sozzi; A Azzarelli; M A Pierotti; S Pilotti
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

7.  Cytosolic SYT/SS18 isoforms are actin-associated proteins that function in matrix-specific adhesion.

Authors:  Jaehong Kim; Mei Swee; William C Parks
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.